On 5/11/2015, the patient’s repeat PSA was down to 0.09 ng/mL (Fig. 1A) and repeat bone scintigraphy showed decreased radiotracer activity in the left ischium and no new evidence of metastatic disease (Fig. 1B–D). This evidence concerns the gene KLK3 and metastatic neoplasm.